Cyclophosphamide Therapy During the Covid19 Pandemic
dc.contributor.author | Bitik, B. | |
dc.contributor.author | Oygur, C. S. | |
dc.contributor.author | Kanbur, A. Yalcintas | |
dc.contributor.author | Yucel, A. E. | |
dc.date.accessioned | 2024-04-03T13:04:35Z | |
dc.date.available | 2024-04-03T13:04:35Z | |
dc.date.issued | 2023 | |
dc.identifier.eissn | 1468-2060 | en_US |
dc.identifier.endpage | 1880 | en_US |
dc.identifier.issn | 0003-4967 | en_US |
dc.identifier.issue | Supplement 1 | en_US |
dc.identifier.startpage | 1879 | en_US |
dc.identifier.uri | https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1879.3.full.pdf | |
dc.identifier.uri | http://hdl.handle.net/11727/11997 | |
dc.identifier.volume | 82 | en_US |
dc.identifier.wos | 001107398706266 | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.1136/annrheumdis-2023-eular.6201 | en_US |
dc.relation.journal | ANNALS OF THE RHEUMATIC DISEASES | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Vasculitis | en_US |
dc.subject | COVID | en_US |
dc.subject | Best practices | en_US |
dc.title | Cyclophosphamide Therapy During the Covid19 Pandemic | en_US |
dc.type | conferenceObject | en_US |